...
首页> 外文期刊>Journal of Surgical Oncology >Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.
【24h】

Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.

机译:升高的术前中性粒细胞与淋巴细胞比率预测在晚期胃癌中切除后的存活率差。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Elevated neutrophil to lymphocyte ratio (N/L ratio) has been shown to be a prognostic indicator in various cancers. We aimed to investigate the prognostic significance of the preoperative N/L ratio in late stage gastric cancer. METHODS: From April 2004 to August 2007, 293 patients who had undergone gastrectomy with curative intent for the AJCC/UICC TNM Stage III or IV gastric cancer were included. N/L ratio was calculated from lymphocyte and neutrophil counts on routine blood tests taken prior to surgery. RESULTS: The median follow-up time for surviving patients was 38.2 months (4.2-65.5 months) and median preoperative N/L ratio was 2.06 (range 0.47-19.73). Subjects were dichotomized at the N/L value of 2.0. A multivariate analysis established a significant relationship between the N/L ratio and overall survival (HR=1.609; 95% confidence interval, CI, 1.144-2.264; P=0.006). The cutoff value up to 3.0, the value of 75 percentiles, showed a significant prognostic effect on disease-free survival (HR=1.654; 95% CI, 1.088-2.515; P=0.019). CONCLUSIONS: The results suggest that the elevated preoperative N/L ratio predicts poor disease-free and overall survival following resection for late stage gastric cancer. It may be utilized as a simple, reliable prognostic factor for risk stratification and will provide better treatment allocation.
机译:背景:升高的中性粒细胞与淋巴细胞比(N / L比)已被证明是各种癌症中的预后指示剂。我们旨在探讨晚期胃癌中术前N / L比的预后意义。方法:从2004年4月到2007年8月,包括293名患有AJCC / UICC TNM阶段III或IV胃癌患者的胃切除术的患者。 N / L与淋巴细胞和中性粒细胞计数计算常规血液试验在手术前进行的。结果:存活患者的中位后续时间为38.2个月(4.2-65.5个月),中位数N / L比为2.06(范围0.47-19.73)。受试者在N / L值为2.0时二分。多变量分析建立了N / L比和总存活之间的显着关系(HR = 1.609; 95%置信区间,CI,1.144-2.264; p = 0.006)。截止值高达3.0,值为75百分位,对无病生存率显着预后效果(HR = 1.654; 95%CI,1.088-2.515; P = 0.019)。结论:结果表明,在晚期胃癌切除后,术前N / L比预测缺乏无疾病和整体存活率。它可以用作风险分层的简单,可靠的预后因素,并将提供更好的治疗分配。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号